MPF conducting research to produce ten more new products this FY

December 24, 2017

Research activities are being carried out by the stateowned Myanmar Pharmaceutical Factory (MPF), formerly known as Burma Pharmaceutical Industry (BPI) in order to manufacture more than ten products this Fiscal Year, said U Ko Ko Aung, the managing director of MPF.

“Our pharmaceutical production is still in a fragile state and so, we are endeavouring to boost output”, he added.

MPF is conducting the research for production of around 12 new products including medications to relief cancer pain, anti-HIV drug and drugs prescribed for heart disease.

MPF can fulfill only 10 per cent of national requirement and total pharmaceutical production of local factories is still less than 15 per cent of the requirement. Most of pharmaceuticals are imported, said U Ko Ko Aung.

During last FY, MPF’s output estimated Ks 28 to 30 billion. Production value this FY increased up to Ks50 billion.

There are two pharmaceutical factories- Myanmar Pharmaceutical Factory (MPF) Insein and Kyaukse. MPF provides a total of 287 products and is making efforts to improve new products. Last FY saw 12 new products by MPF.

U Ko Ko Aung suggested that people should raise awareness of counterfeit drugs under the name of BPI brand and prescription mixed with expired drugs. And so, public need to take a special care to check the bearing of BPI brand in the FILM coated tablets and expired date.

A collaborative inspection such as surprise check was made by Special Investigation Bureau of the Ministry of Home Affairs and MPF under the Ministry of Industry at drugstores, warehouses and drug producing factories in September 2016. Fake BPI tablets, vials and ointments with estimated value of Ks2.8 billion were seized.

May Thet Hnin

Ref; The Global New Light of Myanmar